Delivery Order SPE2DB22D1002-SPE2DB25FLJC9
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Clobazam 10 mg tablets (100-count units) with a ceiling value of $1,555.93. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by May 7, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Clobazam 10 mg tablets in quantities of 100 units, with a ceiling value of $3,124.28 and a firm fixed price contract type. The delivery order is non-set-aside and carries an ultimate completion date of September 29, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $3,143.34 to AmerisourceBergen Drug Corp for Clobazam 10 mg tablets (100-count units) on September 11, 2025, with an ultimate completion date of September 12, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Clobazam 10 mg tablets (100-count) with a ceiling value of $3,414.22. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's substantial pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 15, 2025, for the supply of Clobazam 10 mg tablets (100-count units) with a ceiling value of $2,190.50. This firm fixed-price delivery order, which is not set-aside designated, is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 16, 2025. The contract represents a continuation of AmerisourceBergen's ongoing...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Clobazam 10 mg tablets in quantities of 100 units, with a ceiling value of $6,419.43 and an ultimate completion date of September 9, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The place of performance is AmerisourceBergen's corporate office located in Conshohocken,...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Clobazam 10 mg tablets (100-count units) with a ceiling value of $15,559.30. This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, represents a non-competitive set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Clobazam 10 mg tablets (100 count) valued at $10,427.89 under a firm fixed price contract. The award, issued on August 28, 2025, with an ultimate completion date of August 29, 2025, represents a non-set-aside competitively awarded delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery at its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Clobazam 10 mg tablets in quantities of 100 units, with a ceiling value of $3,111.86. This is a firm fixed price delivery order with no set-aside designation, indicating the award resulted from open competition. The ultimate completion date is September 15, 2025. This delivery order is a child contract issued under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Clobazam 10 mg tablets (100-count) valued at $1,555.93 under a firm fixed price contract. The award was made on July 30, 2025, with an ultimate completion date of July 31, 2025, and represents a non-competitive delivery against an existing contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location in the same city. This delivery...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLJC9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Clobazam 10 mg tablets (100 count) with a ceiling value of $1,015.46 under a firm fixed price contract. This award represents a non-set-aside competitive procurement processed as a delivery order, with an ultimate completion date of September 25, 2025. AmerisourceBergen's Corporate Office, headquartered in Conshohocken, Pennsylvania, will serve as the place of performance for this pharmaceutical supply delivery. This delivery order is issued under AmerisourceBergen's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen has consistently demonstrated capability to meet DLA requirements through competitive awards covering diverse therapeutic domains including specialty medications, brand-name and generic drugs, and medical supplies across the Defense Health Agency and related government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/24/25 |